November 2010 Volume 6, Issue 11
Volume 6, Issue 11 | November 2010
November 2010
In this Issue
Research & Development
Pfizer adds pain jewels to crown
Staking its claim as a leader in the pain relief market, Pfizer acquires King Pharmaceuticals for $3.6 billionFollowing the natural laws of economics
Endo Pharmaceuticals acquires generics giant Qualitest to be more responsive to changing healthcare environmentOncology trifecta
Having signed recent deals with two other top cancer-focused companies, ImmunoGen announces collaboration with Novartis for rights to use TAP TechnologyOne down, two to go
LabCorp enters into definitive agreement to acquire Genzyme Genetics, one of three business units that Genzyme is aiming to offloadCompanies seek game-changer for CKD
Reata, Abbott team up to develop, commercialize bardoxolone methyl to treat chronic kidney diseaseGlobal News
One giant step for Covance … and perhaps other CROs
Covance secures $2.2 billion R&D alliance with sanofi-aventis that may signal a market shift toward outsourcing more pharma servicesMimicry with real results
Sanofi Pasteur to acquire U.S. biotech company VaxDesign and advance its MIMIC technologyAn orthogonal collaboration
Evotec and Shionogi partner in fragment-based drug discovery programPartners take it to the next level
Previous partners Janssen Pharmaceutica and Argenta enter into integrated cancer drug discovery service agreementWhat once was lost could be found
AstraZeneca & UCL collaborate on stem cell solution to diabetic vision lossGovernment Watch
Stem cell debate plays out in court
After a federal court halts Obama administration’s expansion of embryonic stem cell research, an appellate court OKs government funding—for nowOverseas drug deals interest the feds
U.S. drug companies investigated for possible bribesTo disclose or not to disclose?
U.S. Supreme Court to hear arguments in shareholder lawsuit against Matrixx over drug Zicam; decision could impact adverse effect reporting requirementsFDA hosts hearing on biologics issues
Agency seeks input on implementation of Biologics Price Competition and Innovation (BPCI) ActEditor's Focus
A new medium, a new message
Controversy is a curious thing, especially when you throw today’s communication technology into the mix. Everybody has an opinion about everything, and takes to a keyboard to share it with the world.Special Reports
Knowledge is power
Breakthroughs in cancer research are frequently pioneered in the halls of academiaFederal funding and the 40 years’ war on cancer
Government bureaucracy may be thwarting funding of breakthrough cancer researchPatent News
Practicing an industry standard may be basis for patent infringement
The Federal Circuit recently affirmed that an admission that an accused infringing device practicing an industry standard may, without more, be the basis for a finding of infringement.Commentary
Guest Commentary: Bioproduction goes global
Biopharmaceuticals, including monoclonal antibodies and vaccines, make up an increasingly large proportion of drugs on the market and in the development pipeline.Diagnostics
Winning the hand of the girl next door
Combination of MorphoSys and Sloning technologies set to increase success rates in drug developmentCepheid forms collaboration with Novartis
Deal focuses on commercialization of test to monitor the BCR-ABL gene transcript in peripheral blood specimens related to Ph+ chronic myelogenous leukemiaA crystal ball for cancer
Roche, German Cancer Research Center enter research agreement to predict cervical cancerGetting it right the first time
Sirius Genomics and Golden Helix collaborate on sepsis diagnostic developmentInstruments & Informatics
Three-way triple threat
Vivo Biosciences, ACEA Biosciences and Roche to develop xCELLigence System assays for stem cell and cancer researchCapture and release
IDBS and Genomic Health team up to streamline development of oncology diagnostic toolsA sunny solution
Cisbio partners with Blue Sky to target kinasesDiaceutics and London Genetics to develop software for biomarker studies
New product to be launched in 2011 will be based on the Diaceutics Fusion and London Genetics Biomarker Pathway platformsOmics & Systems Biology
Takeda and Envoy form schizophrenia research alliance
Deal calls for $3 million upfront and $2.25 million per year over three yearsGoing with the flow
Thermo Fisher Scientific and Proteome Sciences cement ongoing protein biomarker collaborationThe eyes have it
RXi Pharmaceuticals and EyeGate Pharma see a future together focused on retinal therapiesDomo arigato
Germany’s Kinaxo signs cancer research agreement with Japan’s Daiichi SankyoFeature
Come to Philly to see how far cell biology has come
Marking off a half century of annual meetings and even longer for cell biology scientific progress, the ASCB brings it all together in the ‘City of Brotherly Love’New Products
Round bottom tube for critical cellular applications
Thermo Fisher Scientific Inc. has introduced a new Thermo Scientific Nunc 14 ml round bottom tube for critical cellular applications.
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
A closer look at the tumor microenvironment
New technologies are allowing researchers to delve deeper into the complex tumor landscape.
Exploring stain-free western blotting
Researchers can achieve seamless western blot experiments by implementing advancements in stain-free technology, normalization methods, and compliance integration.
Streamlining biopharmaceutical analysis with digital solutions
Discover how digitization improves data integrity and accelerates decision-making in biotherapeutics development.
